EP4257202A3 - Particules de fibroïne injectables et leurs utilisations - Google Patents

Particules de fibroïne injectables et leurs utilisations Download PDF

Info

Publication number
EP4257202A3
EP4257202A3 EP23168344.2A EP23168344A EP4257202A3 EP 4257202 A3 EP4257202 A3 EP 4257202A3 EP 23168344 A EP23168344 A EP 23168344A EP 4257202 A3 EP4257202 A3 EP 4257202A3
Authority
EP
European Patent Office
Prior art keywords
tissue
compositions
silk fibroin
fibroin particles
augmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23168344.2A
Other languages
German (de)
English (en)
Other versions
EP4257202A2 (fr
Inventor
Evangelia BELLAS
Kacey MARRA
Peter J. RUBIN
David L. Kaplan
James J. Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Tufts University
Wake Forest University Health Sciences
Original Assignee
University of Pittsburgh
Tufts University
Wake Forest University Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh, Tufts University, Wake Forest University Health Sciences filed Critical University of Pittsburgh
Publication of EP4257202A2 publication Critical patent/EP4257202A2/fr
Publication of EP4257202A3 publication Critical patent/EP4257202A3/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Composite Materials (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
EP23168344.2A 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations Pending EP4257202A3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161557603P 2011-11-09 2011-11-09
PCT/US2012/064450 WO2013071107A1 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations
EP12846915.2A EP2788040B1 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP12846915.2A Division EP2788040B1 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations
EP12846915.2A Division-Into EP2788040B1 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations

Publications (2)

Publication Number Publication Date
EP4257202A2 EP4257202A2 (fr) 2023-10-11
EP4257202A3 true EP4257202A3 (fr) 2023-12-20

Family

ID=48290608

Family Applications (2)

Application Number Title Priority Date Filing Date
EP23168344.2A Pending EP4257202A3 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations
EP12846915.2A Active EP2788040B1 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP12846915.2A Active EP2788040B1 (fr) 2011-11-09 2012-11-09 Particules de fibroïne injectables et leurs utilisations

Country Status (12)

Country Link
US (3) US9931434B2 (fr)
EP (2) EP4257202A3 (fr)
JP (2) JP6362540B2 (fr)
KR (3) KR20200093073A (fr)
CN (1) CN104363931A (fr)
AU (2) AU2012335106B2 (fr)
BR (1) BR112014011188B1 (fr)
CA (1) CA2890366A1 (fr)
ES (1) ES2953309T3 (fr)
HK (1) HK1207322A1 (fr)
MX (1) MX2014005702A (fr)
WO (1) WO2013071107A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4257202A3 (fr) 2011-11-09 2023-12-20 Trustees of Tufts College Particules de fibroïne injectables et leurs utilisations
US9925301B2 (en) 2012-04-06 2018-03-27 Trustees Of Tufts College Methods of producing and using silk microfibers
US11376329B2 (en) 2013-03-15 2022-07-05 Trustees Of Tufts College Low molecular weight silk compositions and stabilizing silk compositions
CN103357066B (zh) * 2013-06-28 2015-07-29 陕西巨子生物技术有限公司 一种具有生物修复活性及优良降解性能的水凝胶及制备方法
US20150290248A1 (en) * 2014-04-10 2015-10-15 Nanofiber Health, Inc. Fibrous component for health, performance, and aesthetic treatment
KR20230048175A (ko) * 2014-08-15 2023-04-10 더 존스 홉킨스 유니버시티 조직 복원용 복합 재료
GB201415681D0 (en) 2014-09-04 2014-10-22 Cambridge Entpr Ltd And President And Fellows Of Harvard College Protien Capsules
EP3226835A4 (fr) 2014-12-02 2018-09-26 Silk Therapeutics, Inc. Vêtement de performance de soie, et produits et procédés de préparation de celui-ci
AU2016294611B2 (en) 2015-07-14 2022-08-11 Evolved By Nature, Inc. Silk performance apparel and products and methods of preparing the same
GB201514788D0 (en) 2015-08-20 2015-10-07 Ecole Polytech Malleable scaffold material and uses thereof
EP3414373B1 (fr) 2016-02-11 2024-04-24 Seevix Material Sciences Ltd. Matériaux composites comprenant de la soie d'araignée synthétique de type fil de traîne
KR101710639B1 (ko) * 2016-06-07 2017-03-08 주식회사 파마리서치프로덕트 핵산, 키토산 및 히알루론산을 포함하는 조직 증강용 충전 조성물 및 이의 제조방법
WO2018081815A2 (fr) * 2016-10-31 2018-05-03 Sofregen Medical, Inc. Compositions comprenant des particules de fibroïne de soie et leurs utilisations
JP7220149B2 (ja) 2016-12-28 2023-02-09 サンバイオ，インコーポレイティド 細胞送達システム及びその動作方法
CN106729982A (zh) * 2016-12-29 2017-05-31 浙江大学 一种丝素蛋白纳米球的制备方法
JP6482604B2 (ja) * 2017-06-22 2019-03-13 教裕 南郷 外皮内溶解型ニードル及びニードル装置
CN111712514A (zh) 2017-09-27 2020-09-25 自然进化公司 丝涂布织物和产品及其制备方法
CN115252910A (zh) * 2017-10-18 2022-11-01 生命细胞公司 脂肪组织产品以及产生方法
RU2684769C1 (ru) * 2017-11-22 2019-04-12 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТИО им. ак. В.И. Шумакова" Минздрава России) Композиция для изготовления биодеградируемых скаффолдов и способ ее получения
RU2683557C1 (ru) * 2017-11-22 2019-03-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ТИО им. ак. В.И. Шумакова" Минздрава России) Способ получения биодеградируемых скаффолдов из фиброина шелка с улучшенными биологическими свойствами
KR102034871B1 (ko) * 2018-01-10 2019-11-08 주식회사 지투지바이오 비타민 c가 함유된 폴리카프로락톤 미립구 필러 및 그 제조방법
US20210008249A1 (en) 2018-03-12 2021-01-14 Merz Pharma Gmbh & Co. Kgaa Porous biomaterials for tissue regeneration
EP3790601A1 (fr) 2018-05-09 2021-03-17 The Johns Hopkins University Composites de nanofibres-hydrogel pour le remplacement et la régénération améliorés de tissus mous
CN112384258A (zh) 2018-05-09 2021-02-19 约翰·霍普金斯大学 用于细胞和组织递送的纳米纤维-水凝胶复合物
CN109851819B (zh) * 2019-03-08 2021-10-29 江西丝科生物科技有限公司 一种可注射丝素蛋白多孔水凝胶及其制备方法
US12059507B2 (en) 2019-04-02 2024-08-13 Volumina Medical Sa Composition comprising a cross-linked polyol
US20200354868A1 (en) * 2019-05-07 2020-11-12 Preco, Inc. Containment closure method for containing friable material and contained friable material
AU2020288624A1 (en) 2019-06-04 2022-02-03 Cocoon Biotech Inc. Silk-based products, formulations, and methods of use
CN110384823B (zh) * 2019-07-19 2021-08-03 大连医科大学 基于丝素蛋白支架的仿生肝小叶及构建方法
WO2022104378A1 (fr) * 2020-11-12 2022-05-19 Trustees Of Tufts College Tissu adipeux de culture
US20240033401A1 (en) * 2020-12-18 2024-02-01 Drexel University Injectable, cross-linkable and subcellular size microfibers for soft tissue repair
CN112587721A (zh) * 2020-12-30 2021-04-02 广州益诚生物科技有限公司 一种注射填充材料及制备工艺
CN113069593A (zh) * 2021-04-10 2021-07-06 中国人民解放军总医院 预混氏干细胞分泌蛋白组丝素水凝胶的制作工艺
WO2022232090A2 (fr) * 2021-04-29 2022-11-03 Carnegie Mellon University Biomatériaux à sensibilité acoustique
CN118317973A (zh) * 2021-11-29 2024-07-09 麻省理工学院 用于可溶性和不溶性有效载荷递送的可生物降解的丝基微囊的可调结构
CN115105645B (zh) * 2022-06-28 2023-05-26 北京化工大学 一种复合微球、伤口修复敷料的制备方法
WO2024119107A1 (fr) * 2022-12-01 2024-06-06 Evolved By Nature, Inc. Formes lyophilisées et pulvérisables de fibroïne de soie et de fibroïne de soie modifiée
CN116554507B (zh) * 2023-07-12 2023-09-29 江西丝科生物科技有限公司 蚕丝蛋白双网络水凝胶及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026043A1 (en) * 2003-11-20 2007-02-01 Angiotech International Ag Medical devices combined with diblock copolymer compositions
WO2010042798A2 (fr) * 2008-10-09 2010-04-15 Trustees Of Tufts College Films en soie améliorés contenant du glycérol
US20110172768A1 (en) * 2006-10-19 2011-07-14 Cragg Andrew H Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034135A (en) 1982-12-13 1991-07-23 William F. McLaughlin Blood fractionation system and method
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5245012A (en) 1990-04-19 1993-09-14 The United States Of America As Represented By The Secretary Of The Army Method to achieve solubilization of spider silk proteins
US5234608A (en) 1990-12-11 1993-08-10 Baxter International Inc. Systems and methods for processing cellular rich suspensions
EP0617706B1 (fr) 1991-11-25 2001-10-17 Enzon, Inc. Proteines multivalentes de fixation aux antigenes
BR9612625A (pt) 1995-08-22 1999-06-01 Agricola Tech Inc Processos de clonagem para proteínas de séda de aranha de alta resisténcia
US6287340B1 (en) 1999-05-14 2001-09-11 Trustees Of Tufts College Bioengineered anterior cruciate ligament
JP3771510B2 (ja) * 2001-04-13 2006-04-26 泰彦 田畑 組織の体内再生用材料
EP2662211A1 (fr) 2002-06-24 2013-11-13 Tufts University Biomatériaux à base de soie et leurs procédés d'utilisation
WO2004001103A2 (fr) 2002-06-24 2003-12-31 Tufts University Biomateriaux a base de soie et procedes d'utilisation
WO2004062697A2 (fr) 2003-01-07 2004-07-29 Tufts University Matières de fibroïne de soie et utilisation de celles-ci
CA2562415C (fr) 2003-04-10 2015-10-27 Tufts University Solution aqueuse concentree de fibroine
WO2005000483A1 (fr) 2003-06-06 2005-01-06 Tufts University Procede de formation d'enrobages inorganiques
US20050276791A1 (en) 2004-02-20 2005-12-15 The Ohio State University Multi-layer polymer scaffolds
WO2005123114A2 (fr) 2004-06-11 2005-12-29 Trustees Of Tufts College Systeme d'administration de medicament a base de soie
WO2006042287A2 (fr) 2004-10-12 2006-04-20 Trustees Of Tufts College Procede de production d'echafaudages de biomateriaux
US7960509B2 (en) 2005-01-14 2011-06-14 Trustees Of Tufts College Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
US9290579B2 (en) 2005-04-20 2016-03-22 Trustees Of Tufts College Covalently immobilized protein gradients in three-dimensional porous scaffolds
CA2645934C (fr) 2005-08-02 2014-04-29 Trustees Of Tufts College Procedes de depot progressif de revetements de fibroine
WO2007103442A1 (fr) 2006-03-06 2007-09-13 Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College Matrices biocompatibles et cellules souches issues de tissus adipeux
US20100028451A1 (en) 2006-09-26 2010-02-04 Trustees Of Tufts College Silk microspheres for encapsulation and controlled release
US20100068740A1 (en) 2006-11-03 2010-03-18 Trustees Of Tufts College Microfluidic device with a cylindrical microchannel and a method for fabricating same
JP2010509593A (ja) 2006-11-03 2010-03-25 トラスティーズ オブ タフツ カレッジ バイオポリマーセンサーおよびその製造方法
WO2008127401A2 (fr) 2006-11-03 2008-10-23 Trustees Of Tufts College Guide d'onde optique de biopolymère et procédé de fabrication de celui-ci
WO2008118211A2 (fr) 2006-11-03 2008-10-02 Trustees Of Tufts College Cristaux photoniques biopolymères et procédés de fabrication de ceux-ci
EP2650112B1 (fr) 2006-11-03 2016-08-24 Trustees Of Tufts College Guide d'onde optique de biopolymère et procédé de fabrication de celui-ci
US8975073B2 (en) 2006-11-21 2015-03-10 The Charles Stark Draper Laboratory, Inc. Microfluidic device comprising silk films coupled to form a microchannel
WO2008085904A1 (fr) 2007-01-05 2008-07-17 Charles Stark Draper Laboratory, Inc. Dispositifs électroniques biodégradables
EP2129772B1 (fr) 2007-02-27 2016-07-27 Trustees Of Tufts College Organes de soie produits par génie tissulaire
ES2527125T3 (es) 2007-05-29 2015-01-20 Trustees Of Tufts College Método para la gelificación de fibroína de seda usando sonicación
KR100894265B1 (ko) 2007-06-05 2009-04-21 재단법인서울대학교산학협력재단 골형성 촉진 펩타이드를 함유하는 주입형 골재생재
WO2009061823A1 (fr) 2007-11-05 2009-05-14 Trustees Of Tufts College Fabrication de structures photoniques de fibroïne de soie par impression par nanocontact
EP2237770A4 (fr) * 2007-12-26 2011-11-09 Gel Del Technologies Inc Particules de protéines biocompatibles, dispositifs à particules et leurs procédés
CA2713251A1 (fr) 2008-02-07 2009-08-13 Trustees Of Tufts College Compositions d'hydroxyapatite et de soie en trois dimensions
US8206774B2 (en) 2008-03-13 2012-06-26 Trustees Of Tufts College Diazonium salt modification of silk polymer
US9068282B2 (en) 2008-04-08 2015-06-30 Trustees Of Tufts College System and method for making biomaterial structures
US20110135697A1 (en) 2008-06-18 2011-06-09 Trustees Of Tufts College Edible holographic silk products
US9427499B2 (en) 2008-11-17 2016-08-30 Trustees Of Tufts College Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
WO2010123946A2 (fr) * 2009-04-20 2010-10-28 Allergan, Inc. Hydrogels à base de fibroïnes de soie et leurs utilisations
US20110189292A1 (en) * 2009-04-20 2011-08-04 Allergan, Inc. Dermal fillers comprising silk fibroin hydrogels and uses thereof
US20120070427A1 (en) 2009-06-01 2012-03-22 Trustees Of Tufts College Vortex-induced silk fibroin gelation for encapsulation and delivery
CA2805403A1 (fr) 2009-07-10 2011-01-13 Trustees Of Tufts College Systeme d'administration d'acide nucleique a base de proteine de soie biologiquement modifiee
US8293486B2 (en) 2009-07-21 2012-10-23 Trustees Of Tufts College Functionalization of silk material by avidin-biotin interaction
CN102188753B (zh) * 2011-05-10 2013-10-09 中原工学院 一种含有柞蚕丝素的纳米骨仿生材料及其制备方法
KR102176406B1 (ko) * 2011-11-09 2020-11-09 트러스티즈 오브 터프츠 칼리지 주사가능한 실크 피브로인 발포체 및 그의 용도
EP4257202A3 (fr) 2011-11-09 2023-12-20 Trustees of Tufts College Particules de fibroïne injectables et leurs utilisations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026043A1 (en) * 2003-11-20 2007-02-01 Angiotech International Ag Medical devices combined with diblock copolymer compositions
US20110172768A1 (en) * 2006-10-19 2011-07-14 Cragg Andrew H Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis
WO2010042798A2 (fr) * 2008-10-09 2010-04-15 Trustees Of Tufts College Films en soie améliorés contenant du glycérol

Also Published As

Publication number Publication date
EP2788040A1 (fr) 2014-10-15
KR102138152B1 (ko) 2020-07-27
WO2013071107A1 (fr) 2013-05-16
JP2015502199A (ja) 2015-01-22
KR20230066481A (ko) 2023-05-15
ES2953309T3 (es) 2023-11-10
AU2012335106B2 (en) 2016-09-01
US20210244850A1 (en) 2021-08-12
EP2788040A4 (fr) 2015-05-06
MX2014005702A (es) 2015-02-17
BR112014011188B1 (pt) 2020-05-19
EP2788040B1 (fr) 2023-05-24
CA2890366A1 (fr) 2013-05-16
JP6362540B2 (ja) 2018-07-25
US9931434B2 (en) 2018-04-03
JP2018089388A (ja) 2018-06-14
HK1207322A1 (en) 2016-01-29
KR20140102208A (ko) 2014-08-21
AU2012335106A1 (en) 2014-06-26
BR112014011188A2 (pt) 2017-05-09
US20180339084A1 (en) 2018-11-29
US20140308362A1 (en) 2014-10-16
BR112014011188A8 (pt) 2018-05-29
EP4257202A2 (fr) 2023-10-11
AU2016262684A1 (en) 2016-12-15
CN104363931A (zh) 2015-02-18
KR20200093073A (ko) 2020-08-04

Similar Documents

Publication Publication Date Title
EP4257202A3 (fr) Particules de fibroïne injectables et leurs utilisations
MX2014005704A (es) Espumas de fibroina de seda inyectables y sus usos.
WO2018081815A3 (fr) Compositions comprenant des particules de fibroïne de soie et leurs utilisations
WO2011110894A3 (fr) Composition fluide pour l'amélioration d'états cutanés
CL2011001963A1 (es) Metodo para reducir o prevenir el daño causado por la piraclostrobina a las plantas y/o material de propagacion vegetal tratados con ella, el cual comprende tratarlos con piraclostrobina combinada con dimetomorf; uso de dimetomorf combinado con piraclostrobina; y composición que comprende dimetomorf y piraclostrobina.
IL272674A (en) Preparations for use in the treatment or prevention of graft-versus-graft disease or diffuse nodal bleeding or venous occlusive disease associated with hematopoietic allograft transplantation
WO2010040129A3 (fr) Echafaudages pour ingénierie tissulaire et médecine régénératrice
MX346958B (es) Composición hemostatica.
MX2014004477A (es) Composiciones hemostaticas.
BR112014012789A2 (pt) agentes terapêuticos compreendendo sequências de aminoácidos de insulina
BR112014014591A2 (pt) processo para a expansão in vitro de células t específicas de antígeno, produto de células t autólogas ou alogênicas expandidas, composição farmacêutica, e, método de tratamento de um paciente, e, usos de uma linhagem de células engenheirada, de células dendríticas pulsadas com misturas de antígeno-peptídeo, de t-apcs pulsadas com misturas de antígeno-peptídeo/peptídeo, e de misturas de antígeno-peptídeo com pbmcs
AR072601A1 (es) Particulas de entrega
EP2392358A3 (fr) Greffes chirurgicales pour réparer des défauts chondraux
EA201391602A1 (ru) Контролируемое высвобождение иммунодепрессантов из синтетических наноносителей
EP2740498A3 (fr) Compositions et procédés de remplissage et de régénération de tissus
WO2010054013A3 (fr) Produits de construction d'échafaudage cellulaire
WO2014151091A3 (fr) Compositions et procédés pour une matrice d'os spongieux
WO2011082038A3 (fr) Compositions de reprogrammation améliorées
BR112015004650A2 (pt) implantes ósseos de compósito
SG11201405875PA (en) Methods and compositions for regenerating and repairing damaged tissue using nonviable irradiated or lyophilized pluripotent stem cells
MX355924B (es) Composicion hemostatica.
PL2064317T3 (pl) Izolowanie komórek
WO2014152102A3 (fr) Implants pour greffe osseuse poreux et bioactifs
WO2013060769A3 (fr) Compositions hémostatiques
WO2009086305A3 (fr) Mastics ostéo-inducteurs et leurs procédés de fabrication et d'utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AC Divisional application: reference to earlier application

Ref document number: 2788040

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61P0043000000

Ipc: A61L0027220000

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 43/00 20060101ALI20231115BHEP

Ipc: A61P 21/00 20060101ALI20231115BHEP

Ipc: A61P 19/04 20060101ALI20231115BHEP

Ipc: A61P 17/00 20060101ALI20231115BHEP

Ipc: A61P 15/08 20060101ALI20231115BHEP

Ipc: A61L 27/58 20060101ALI20231115BHEP

Ipc: A61L 27/56 20060101ALI20231115BHEP

Ipc: A61L 27/48 20060101ALI20231115BHEP

Ipc: A61L 27/38 20060101ALI20231115BHEP

Ipc: A61L 27/36 20060101ALI20231115BHEP

Ipc: A61M 5/178 20060101ALI20231115BHEP

Ipc: A61M 25/00 20060101ALI20231115BHEP

Ipc: A61L 27/14 20060101ALI20231115BHEP

Ipc: A61L 27/54 20060101ALI20231115BHEP

Ipc: A61L 27/22 20060101AFI20231115BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240620

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR